1. Home
  2. HBIO vs PRPO Comparison

HBIO vs PRPO Comparison

Compare HBIO & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.70

Market Cap

33.8M

Sector

Industrials

ML Signal

HOLD

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$24.02

Market Cap

32.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
HBIO
PRPO
Founded
1901
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
32.4M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
HBIO
PRPO
Price
$0.70
$24.02
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$2.50
N/A
AVG Volume (30 Days)
1.0M
14.5K
Earning Date
11-06-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$87,371,000.00
$22,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.95
52 Week Low
$0.28
$3.90
52 Week High
$2.36
$28.50

Technical Indicators

Market Signals
Indicator
HBIO
PRPO
Relative Strength Index (RSI) 53.04 53.44
Support Level $0.71 $24.00
Resistance Level $0.78 $25.62
Average True Range (ATR) 0.06 1.24
MACD -0.01 -0.18
Stochastic Oscillator 13.28 43.43

Price Performance

Historical Comparison
HBIO
PRPO

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: